ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 250 filers reported holding ALKERMES PLC in Q4 2017. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,015 | -10.5% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $46,950 | +11.0% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $42,285 | +7.9% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $39,195 | +18.8% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $33,000 | -26.7% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $45,000 | +15.4% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $39,000 | +11.4% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $35,000 | -88.4% | 1,500 | -87.9% | 0.00% | -83.3% |
| Q2 2021 | $303,000 | +31.2% | 12,350 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $231,000 | +391.5% | 12,350 | +425.5% | 0.01% | +200.0% |
| Q4 2020 | $47,000 | +74.1% | 2,350 | +46.9% | 0.00% | +100.0% |
| Q3 2020 | $27,000 | -12.9% | 1,600 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $31,000 | +34.8% | 1,600 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $23,000 | +64.3% | 1,600 | +128.6% | 0.00% | +100.0% |
| Q4 2019 | $14,000 | 0.0% | 700 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $14,000 | -12.5% | 700 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $16,000 | -38.5% | 700 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $26,000 | -99.8% | 700 | -99.7% | 0.00% | -97.7% |
| Q3 2017 | $13,045,000 | -29.4% | 256,571 | -19.6% | 0.04% | -27.9% |
| Q2 2017 | $18,489,000 | +23.9% | 318,941 | +25.0% | 0.06% | +32.6% |
| Q1 2017 | $14,927,000 | +4.6% | 255,170 | -0.6% | 0.05% | 0.0% |
| Q4 2016 | $14,272,000 | +1615.4% | 256,799 | +1352.5% | 0.05% | +1433.3% |
| Q3 2016 | $832,000 | -14.5% | 17,680 | -21.4% | 0.00% | -25.0% |
| Q2 2016 | $973,000 | +42.9% | 22,500 | +12.9% | 0.00% | +33.3% |
| Q1 2016 | $681,000 | -57.8% | 19,922 | -2.0% | 0.00% | -62.5% |
| Q4 2015 | $1,613,000 | +0.9% | 20,322 | -25.3% | 0.01% | 0.0% |
| Q3 2015 | $1,598,000 | +24.3% | 27,220 | +36.1% | 0.01% | +33.3% |
| Q2 2015 | $1,286,000 | +18.5% | 19,999 | +12.4% | 0.01% | +20.0% |
| Q1 2015 | $1,085,000 | +301.9% | 17,799 | +182.5% | 0.01% | +400.0% |
| Q3 2014 | $270,000 | -42.9% | 6,300 | -33.0% | 0.00% | -50.0% |
| Q2 2014 | $473,000 | +155.7% | 9,400 | +123.8% | 0.00% | +100.0% |
| Q1 2014 | $185,000 | -50.5% | 4,200 | -54.3% | 0.00% | -50.0% |
| Q4 2013 | $374,000 | – | 9,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 14,040,000 | $313,513,000 | 35.43% |
| Krensavage Asset Management, LLC | 1,411,682 | $31,523,000 | 10.04% |
| Prosight Management, LP | 502,150 | $11,213,000 | 6.01% |
| Hardman Johnston Global Advisors LLC | 5,734,259 | $128,046,000 | 5.76% |
| 13D Management LLC | 415,055 | $9,268,000 | 4.85% |
| Ally Bridge Group (NY) LLC | 300,000 | $6,699,000 | 4.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 593,000 | $13,248,000 | 4.25% |
| GREAT POINT PARTNERS LLC | 507,500 | $11,332,000 | 2.73% |
| Tamarack Advisers, LP | 200,000 | $4,466,000 | 2.62% |
| Zebra Capital Management LLC | 22,134 | $494,000 | 1.88% |